Evidence map›Paper›PMID 27063347›Full record

ReviewChest2016

ICU-Acquired Weakness.

Sarah E Jolley, Aaron E Bunnell, Catherine L Hough

2 registry-linked trialsAbstract readReview
In one paragraph

Review in Chest, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 146 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
146citing papers in PubMed, 10 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04914065 completednot on this mapstarted 2020, after this paper: background citation

Predictors of Prognosis in Patients With Critical Illness.

TypeobservationalSponsorTaoyuan General HospitalRan2020 to 2021Enrolled400ConditionsICU Acquired Weakness, Weaning Failure, Quality of LifeArmsRegular care in the surgery intensive care unit
NCT05154786 nacompletednot on this mapstarted 2022, after this paper: background citation

The Effects of Early Mobilization and Endurance Training for Patients With Prolonged Mechanical Ventilator

TypeinterventionalSponsorTaichung Tzu Chi HospitalRan2022 to 2022Enrolled40ConditionsMechanical Ventilation ComplicationArmsEarly Mobilization and endurance training, Usual Care
3 · Its place in the literature

Who cites it

146 citing papers in PubMed, 10 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. ICU-acquired weakness.Intensive care medicine · 2020
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Review
  17. Article
  18. Article
  19. Observational
  20. Review

86 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sarah E JolleySection of Pulmonary/Critical Care Medicine and Allergy/Immunology, Louisiana State University Health Sciences Center, New Orleans, LA.
Aaron E BunnellDepartment of Rehabilitation Medicine, Harborview Medical Center, University of Washington, Seattle, WA.
Catherine L HoughDivision of Pulmonary and Critical Care Medicine, Harborview Medical Center, University of Washington, Seattle, WA. Electronic address: cterrlee@uw.edu.

Funding

Tracking & Evaluation CoreU54GM104940 · NIGMS · LSU PENNINGTON BIOMEDICAL RESEARCH CTR · PI JUDD E SHELLITO · 2012 to 2026
$69.1M
NIGMS NIH HHS U54 GM104940
6 · The paper itself

Abstract

Survivorship after critical illness is an increasingly important health-care concern as ICU use continues to increase while ICU mortality is decreasing. Survivors of critical illness experience marked disability and impairments in physical and cognitive function that persist for years after their initial ICU stay. Newfound impairment is associated with increased health-care costs and use, reductions in health-related quality of life, and prolonged unemployment. Weakness, critical illness neuropathy and/or myopathy, and muscle atrophy are common in patients who are critically ill, with up to 80% of patients admitted to the ICU developing some form of neuromuscular dysfunction. ICU-acquired weakness (ICUAW) is associated with longer durations of mechanical ventilation and hospitalization, along with greater functional impairment for survivors. Although there is increasing recognition of ICUAW as a clinical entity, significant knowledge gaps exist concerning identifying patients at high risk for its development and understanding its role in long-term outcomes after critical illness. This review addresses the epidemiologic and pathophysiologic aspects of ICUAW; highlights the diagnostic challenges associated with its diagnosis in patients who are critically ill; and proposes, to our knowledge, a novel strategy for identifying ICUAW.

Indexed as

Critical IllnessIntensive Care UnitsActivities of Daily LivingHumansLength of StayNeuromuscular DiseasesQuality of LifeRisk Factorscritical illness myopathycritical illness polyneuropathyICU-acquired weaknessICU neuromuscular dysfunctionICU rehabilitation

Identifiers

PMID27063347
PMCPMC5103015

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.